search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


REspiratory Support in COPD after acUte Exacerbation.


- candidate number2768
- NTR NumberNTR1100
- ISRCTNISRCTN wordt niet meer aangevraagd
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR25-sep-2007
- Secondary IDs2007/160 
- Public TitleREspiratory Support in COPD after acUte Exacerbation.
- Scientific TitleThe effect of chronic nocturnal non-invasive ventilatory support at home after ventilatory support during acute respiratory failure in patients with Chronic Obstructive Pulmonary Disease (COPD).
- ACRONYMRESCUE
- hypothesisDoes chronic nocturnal ventilatory support at home after acute respiratory failure treated by (N)IV lead to a prolongation in time to readmission to hospital due to any following exacerbations in these patients compared to medical treatment only.
- Healt Condition(s) or Problem(s) studiedCOPD, Respiratory failure
- Inclusion criteria1. Chronic Obstructive pulmonary disease (COPD), GOLD severity stage 3 and 4;
2. Minimally 48 hours without ventilatory support after invasive or non invasive ventilatory support during an acute respiratory failure and maximally until discharge;
3. Persistent hypercapnia (PaCO2 > 6.0 kPa) during daytime at rest without ventilatory support.
- Exclusion criteria1. Age < 18 or =>75 years;
2. Significant bronchiectasis with recurrent infections;
3. Significant heart failure;
4. Kyphoscoliosis;
5. Neuromuscular disease;
6) Obstructive sleep apnea (Apnea Hypopnea Index: AHI >15 /hr);
7. Current use of Continuous Positive Airway Pressure (CPAP) or Bilevel Positive Airway Pressure (BiPAP);
8. Insufficient motivation for chronic ventilatory support;
9. Social circumstances making chronic ventilatory support impossible;
10. Other disease factors limiting life expectations.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-nov-2007
- planned closingdate1-nov-2009
- Target number of participants200
- InterventionsThe intervention group will receive non-invasive ventilatory support at night at home as well as medical treatment, and the control group will receive standard medical treatment only for the duration of 1 year.
- Primary outcomeTime to event is the primary study outcome, for which an event is defined as a readmission to hospital due to an exacerbation or death.
- Secondary outcome1. Exacerbations;
2. Health related quality of life;
3. Total readmission rate;
4. Total event rate;
5. Survival;
6. Medical costs;
7. Dyspnoea;
8. Activities of daily living;
9. Exercise tolerance;
10. Blood gasses PaO2 and PaCo2;
11. Lung function;
12. Inflammation (systemic) markers*;
13. Muscle strength*;
14. Nutritional status*;
* if possible in specialised centres.
- TimepointsBaseline, 3, 6 and 12 months.
- Trial web siteN/A
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESDrs. F.M. Struik
- CONTACT for SCIENTIFIC QUERIESDrs. F.M. Struik
- Sponsor/Initiator University Medical Center Groningen (UMCG), Department of Pulmonology
- Funding
(Source(s) of Monetary or Material Support)
Longfonds The Netherlands
- PublicationsN/A
- Brief summaryRationale: Currently, chronic ventilatory support for patients with neuromuscular disease and kyphoscoliosis in the Netherlands is routinely managed by 4 home mechanical ventilation (HMV) centres. In contrast, there is no consensus yet how to treat patients with COPD with chronic respiratory failure after an acute event, due to the lack of studies in this area. However, some patients in the Netherlands do receive chronic non invasive ventilation (NIV) after an acute event, while no evidence is available about its effect in the Netherlands or elsewhere. This is the reason why we want to investigate if chronic nocturnal NIV at home is effective in unstable patients with COPD, who remain hypercapnic after ventilatory support during acute respiratory failure.
Objective: The objective of this study is to investigate if chronic nocturnal ventilatory support at home after acute respiratory failure treated by ventilatory support either invasively or non-invasively leads to a prolongation in time to readmission to hospital for an acute exacerbation, improves quality of life, survival and cost-effectiveness in these patients compared to medical treatment only.
Study design: The protocol concerns a multi-centre, prospective, randomized, controlled study.
Study population: The study will be done in patients with Chronic Obstructive Pulmonary Disease (COPD) who remain hypercapnic after an exacerbation with acute respiratory failure treated in hospital by ventilatory support either invasively or non-invasively. Intervention: It will take 2 years to include all 200 patients from which 100 will receive non-invasive ventilatory support at night at home as well as medical treatment, and 100 comprise the control group who will receive medical treatment only, for the duration of 1 year.
Main study parameters/endpoints: Primary study parameter: time to readmission. Secondary parameters; health related quality of life, readmission rate, survival, medical costs, dyspnoea, ADL, exercise tolerance, blood gasses, lung function, muscle strength, nutritional status.
- Main changes (audit trail)
- RECORD25-sep-2007 - 30-jun-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl